Identifiable Intangible Assets (Tables)

6 Months Ended

Jul. 04, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The following summarizes the components of Identifiable intangible assets:
	July 4, 2021						December 31, 2020
(MILLIONS)	Gross Carrying Amount		Accumulated Amortization		Identifiable Intangible Assets, less Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Identifiable Intangible Assets, less Accumulated Amortization
Finite-lived intangible assets
Developed technology rights(a)	$	74,370	$	(52,754)	$	21,616	$	73,545	$	(50,902)	$	22,643
Brands	922		(791)		131		922		(774)		148
Licensing agreements and other	2,290		(1,248)		1,042		2,292		(1,186)		1,106
	77,582		(54,793)		22,789		76,759		(52,862)		23,896
Indefinite-lived intangible assets
Brands	827				827		827				827
IPR&D	3,134				3,134		3,175				3,175
Licensing agreements and other	573				573		573				573
	4,535				4,535		4,575				4,575
Identifiable intangible assets(b)	$	82,116	$	(54,793)	$	27,323	$	81,334	$	(52,862)	$	28,471

(a)The increase in the gross carrying amount primarily reflects $500 million of capitalized BNT162b2 sales milestones to BioNTech.

(b)The decrease is primarily due to amortization, partially offset by the capitalization of the BNT162b2 milestones described above.

Schedule of Indefinite Lived Intangible Assets

The following summarizes the components of Identifiable intangible assets:
	July 4, 2021						December 31, 2020
(MILLIONS)	Gross Carrying Amount		Accumulated Amortization		Identifiable Intangible Assets, less Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Identifiable Intangible Assets, less Accumulated Amortization
Finite-lived intangible assets
Developed technology rights(a)	$	74,370	$	(52,754)	$	21,616	$	73,545	$	(50,902)	$	22,643
Brands	922		(791)		131		922		(774)		148
Licensing agreements and other	2,290		(1,248)		1,042		2,292		(1,186)		1,106
	77,582		(54,793)		22,789		76,759		(52,862)		23,896
Indefinite-lived intangible assets
Brands	827				827		827				827
IPR&D	3,134				3,134		3,175				3,175
Licensing agreements and other	573				573		573				573
	4,535				4,535		4,575				4,575
Identifiable intangible assets(b)	$	82,116	$	(54,793)	$	27,323	$	81,334	$	(52,862)	$	28,471

(a)The increase in the gross carrying amount primarily reflects $500 million of capitalized BNT162b2 sales milestones to BioNTech.

(b)The decrease is primarily due to amortization, partially offset by the capitalization of the BNT162b2 milestones described above.